Snake venom fuels new drug breakthroughs
The auto-injector presses against a pinched fold of skin and delivers its dose with little discomfort. For many, it’s become a routine gesture—no more remarkable than taking a vitamin. The hormone pools in fat tissue, binds to albumin, and slowly releases into the bloodstream over days. What follows—weight loss, improved blood sugar control—still surprises doctors and patients alike.
This medical advance didn’t begin in a lab. It started with a venomous lizard from the Desert Southwest.
The hidden medicine cabinet in nature’s deadliest weapons
Venom is often seen as nature’s most efficient killer. A single milligram of inland taipan venom—roughly the weight of a grain of salt—can be fatal. Yet to scientists and pharmaceutical companies, these toxic cocktails offer something different: a vast, unused source of potential drugs.
For over 100 million years, evolution has refined venoms into precise weapons. Snakes, lizards, fish, scorpions, and other creatures produce complex mixtures of peptides and proteins designed to paralyze, destroy tissue, or induce cardiac arrest. What once threatened human life is now being turned into treatments for chronic diseases.
The process starts with extraction. Scientists collect venom from live animals, then separate it into individual components through fractionation. Each molecule is tested for its effects on biological targets. Some are discarded; others become the foundation for new medications. The challenge lies in modifying these natural compounds to be safe for humans—transforming a molecule that causes hypovolemic shock into one that gently lowers blood pressure.
An associate professor at Louisiana State University notes that venom-derived drugs undergo the same strict clinical trials as any other pharmaceutical. The path from venom to pharmacy can take a decade or more.
From snake venom to blockbuster drugs
The best-known example is captopril, the first oral ACE inhibitor. In 1965, Brazilian pharmacologist Sérgio Henrique Ferreira found that peptides in the venom of the Bothrops jararaca pit viper blocked an enzyme essential to blood pressure regulation. The same mechanism that made the snake deadly became the basis for a life-saving drug. Captopril received FDA approval in 1981, and its derivatives now form a cornerstone of hypertension and heart failure treatment worldwide.
Related: Diabetes Association Chief Apologizes, Vows to Rebuild Trust
Ziconotide, derived from cone snail venom, provides another important development. It delivers powerful pain relief without the risk of addiction, offering a critical alternative for patients with severe chronic pain.
The discovery from the Gila monster may have had the biggest cultural impact. A peptide in its saliva, exendin-4, led to exenatide and the entire GLP-1 class of medications. Today, drugs like Ozempic and Mounjaro are changing how diabetes and obesity are treated, while also sparking discussions about weight, health, and medical innovation.
These successes show that venom’s potential is just starting to be explored.
The Bothrops jararaca, the snake behind ACE inhibitors, illustrates how little-known species can yield critical medical breakthroughs. Before its venom was studied, few would have prioritized its conservation. Yet its disappearance would have deprived millions of a critical medication. The same applies to countless other species, many of which vanish before researchers can examine them.
Habitat destruction speeds up these losses. Tropical forests are cleared at a rate of 18 soccer fields per minute. Freshwater species populations have dropped by 85% in recent decades. Insect numbers have fallen by half in the last 40 years. With about half of all FDA-approved drugs originating from natural sources, the consequences are clear: the extinction of a single species could mean the loss of a future cure.
Venom-based drugs result from eons of evolutionary refinement—molecules designed to interact with precise biological targets. A chemist might spend a lifetime trying to replicate what a snake or scorpion produces naturally.
Airlines often rely on doctors during in-flight emergencies, but the same urgency isn’t always applied to preserving the natural world that fuels medical breakthroughs.
Related Stories
Insurance Coverage Desk Guide to Spinal Injury Compensation Claims in the UK
Insurance Coverage Desk Snake venom fuels new drug breakthroughs
Insurance Coverage Desk New York Boys Club Fosters Mental Health Through Tradition
Insurance Coverage Desk